CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura
Clin Mol Hepatol. 2022;28(2):269-272.   Published online 2022 February 15    DOI: https://doi.org/10.3350/cmh.2022.0040

Excel Download

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
Clinical and Molecular Hepatology. 2022;28(2):269-272   Crossref logo
Link1 Link2 Link3

Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
. 2021;   Crossref logo
Link1 Link2

Validation of Fatty Liver Index as a Marker for Metabolic Dysfunction-Associated Fatty Liver Disease
. 2021;   Crossref logo
Link1 Link2

Validation of Fatty Liver Index as a Marker for Metabolic Dysfunction-associated Fatty Liver Disease
. 2021;   Crossref logo
Link1 Link2

Prevalence of Significant and Advanced Hepatic Fibrosis in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)
. 2021;   Crossref logo
Link1 Link2

Insulin-related biomarkers and their relationship with hepatic fibrosis risk in patients with psoriasis, metabolic syndrome and non-alcoholic fatty liver disease
Journal of Gastroenterology. 2013;48(5):671-672   Crossref logo
Link1 Link2 Link3

A Noninvasive Scoring System for Liver Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease
Gastro Hep Advances. 2022;1(6):1006-1013   Crossref logo
Link1 Link2

Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
Diabetology & Metabolic Syndrome. 2022;14(1):   Crossref logo
Link1 Link2 Link3

The Shift from nonalcoholic fatty liver disease to metabolic dysfunction–associated fatty liver disease
Clinical Liver Disease. 2022;20(5):157-161   Crossref logo
Link1 Link2 Link3

Metabolic dysfunction‐associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in Malaysia
Seminars in Dialysis. 2022;   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.